| Patent No. | Patent Title: |
| 5652332 | Biologically active peptides from functional domains of bact... |
| 5652335 | Physiologically active substance well capable of permeating biome... |
| 5639729 | Tripeptides useful in immune and CNS therapy |
| 5616686 | Polypeptide of a hybrid surface protein by bacteria |
| 5593962 | Fibrillated calcitonin pharmaceutical compositions |
| 5565548 | Pre-S gene coded peptide hepatitis B immunogens and synthetic lip... |
| 5548062 | Tumor cell invasion-inhibiting peptides, peptide complexes and ca... |
| 5538946 | Hirudin derivatives with delayed action |
| 5534494 | Polypeptide compounds having growth hormone releasing activity |
| 5527777 | Peptide compounds, in particular LHRH-antagonists |
| 5521284 | Human cancer inhibitory pentapeptide amides and esters |
| 5521157 | Modified polypeptide compound with VIP-like activity |
| 5516755 | Antitumor and antibacterial peptide and methods of use |
| 5514649 | Antibiotic GE 2270 factors C2a |
| 5512656 | Thymosin alpha-1 derivatives |
| 5504190 | Equimolar multiple oligomer mixtures, especially oligopeptide mix... |
| 5495000 | Anticoagulant peptides |
| 5492894 | Compositions for treating wrinkles comprising a peptide |
| 5488035 | Peptide with inhibitory activity towards plant pathogenic fungi |
| 5484767 | Substantially pure steroidogenesis inducing protein and uses ther... |
| 5484770 | Peptide compounds which inhibit the proliferation of epidermal or... |
| 5480869 | Anti-inflammatory peptide analogs and treatment to inhibit vascul... |
| 5472944 | Suppression of megakaryocytopoiesis by neutrophil activating pept... |
| 5468728 | Use of orally absorbable motilin preparations to enhance motility... |
| 5468730 | Methods for the treatment of non-IgE-mediated diseases |
| 5466669 | Immunostimulatory agent |
| 5462926 | Neuromedin B receptor antagonists which demonstrate selectivity |
| 5461035 | Short peptides with insulin activity |
| 5455227 | Biologically active lipoprotein and its use |
| 5449752 | Polypeptides with affinity to lipopolysaccharides and their uses |
| 5447912 | Erection-inducing methods and compositions |
| 5446025 | Formulations and method of the percutaneous administration of leu... |
| 5446129 | Peptide or its salt for autoimmune hyperthyroidism containing it |
| 5444044 | Synthetic polypeptides as inhibitors of HIV-1 |
| 5440015 | Selectin peptide medicaments for treating disease |
| 5438119 | Method of obtaining a peptide with desired target property |
| 5436221 | Tumor metastasis inhibiting compounds and methods |
| 5436222 | Use of platelet factor 4 to treat inflammatory diseases |
| 5434136 | Treatment of motility disorders with a GNRH analog |
| 5432262 | Method of purifying -L-aspartyl-L-phenylalanine methyl est... |